Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin (2016 - 2025)

Cumberland Pharmaceuticals' Net Margin history spans 15 years, with the latest figure at 7.89% for Q4 2025.

  • For Q4 2025, Net Margin rose 741.0% year-over-year to 7.89%; the TTM value through Dec 2025 reached 5.65%, up 1053.0%, while the annual FY2025 figure was 5.65%, 1056.0% up from the prior year.
  • Net Margin for Q4 2025 was 7.89% at Cumberland Pharmaceuticals, up from 23.5% in the prior quarter.
  • Across five years, Net Margin topped out at 10.66% in Q1 2025 and bottomed at 23.5% in Q3 2025.
  • The 4-year median for Net Margin is 6.78% (2025), against an average of 4.58%.
  • The largest annual shift saw Net Margin plummeted -2426bps in 2024 before it soared 3304bps in 2025.
  • A 4-year view of Net Margin shows it stood at 6.05% in 2021, then tumbled by -274bps to 10.54% in 2023, then plummeted by -45bps to 15.3% in 2024, then skyrocketed by 48bps to 7.89% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Net Margin are 7.89% (Q4 2025), 23.5% (Q3 2025), and 6.78% (Q2 2025).